The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Net income | 52,330 | 50,966 | 28,380 | 36,191 |
| Depreciation and amortization | 14,401 | 13,178 | 12,705 | 40,809 |
| Amortization of deferred financing fees | 787 | 787 | 787 | 782 |
| Stock-based compensation | 12,516 | 13,604 | 12,202 | 12,304 |
| Loss on investment in partnership | -488 | -312 | - | -993 |
| Gain on insurance subsidiary deposits and investments | 1,140 | 1,212 | 1,652 | -942 |
| Deferred taxes | -14,508 | 2,551 | -19,580 | 766 |
| Noncash lease expense | 11,931 | 12,437 | 12,703 | 11,674 |
| Other noncash operating activities, net | 81 | -269 | 298 | 0 |
| Accounts receivable, net | -9,847 | -42,549 | 38,901 | 67,133 |
| Other receivables | 14,783 | -9,380 | -13,721 | 25,421 |
| Prepaid expenses and other current assets | -16,873 | 35,636 | -11,800 | 12,098 |
| Other assets | -6,842 | 10,693 | 3,833 | -1,541 |
| Escrow funds | 1,012 | 1,596 | -3,312 | 1,538 |
| Operating lease liabilities | -328 | -1,069 | 64 | 129 |
| Accounts payable | 31,807 | -25,346 | 20,606 | 23,059 |
| Accrued payroll and benefits | 62,402 | -17,487 | 61,446 | -9,610 |
| Accrued self-insurance liabilities | 7,306 | 28,919 | 21,224 | 18,649 |
| Refund liability | 7,538 | 11,441 | 16,359 | 61,808 |
| Other accrued expenses | -68,575 | 83,595 | 22,280 | 35,916 |
| Other liabilities | 69,993 | -123,837 | -23,677 | -37,280 |
| Net cash provided by operating activities | 204,796 | 52,574 | 150,244 | 64,590 |
| Investment in partnerships | 0 | 0 | 0 | 2,465 |
| Non-operating distributions from investment in partnership | 1,354 | 1,521 | 1,301 | 1,305 |
| Purchase of available-for-sale securities | 51 | 15,111 | 0 | 45,874 |
| Sale of available-for-sale securities | - | - | - | 25,874 |
| Acquisition of facilities | 80,351 | 243 | 0 | 58,583 |
| Purchase of property and equipment | 18,010 | 18,572 | 17,717 | 24,591 |
| Proceeds from the sale of assets | 0 | - | - | 0 |
| Net cash used in investing activities | -97,058 | -32,405 | -16,416 | -104,334 |
| Borrowing on line of credit, net of deferred financing fees | 0 | 0 | 0 | 274,000 |
| Payments on line of credit | 42,000 | 0 | 0 | 132,000 |
| Borrowings of long-term debt, net of deferred financing fees | 0 | 0 | 0 | 2,189 |
| Payments on long-term debt | 3,726 | 4,957 | 4,065 | 5,616 |
| Noncontrolling interest distribution | 158 | 220 | - | - |
| Contributions from noncontrolling interest | 0 | 0 | - | 0 |
| Dividends on common stock | 0 | 0 | 0 | 0 |
| Proceeds from initial public offering, net of issuance costs | 0 | 0 | - | 0 |
| Proceeds from common stock offering, net of issuance costs | 0 | - | - | 0 |
| Taxes paid related to net share settlement of stock-based compensation awards | 440 | 7,955 | - | -1 |
| Net cash used in financing activities | -46,324 | -13,132 | -4,065 | 138,574 |
| Net change in cash | 61,414 | 7,037 | 129,763 | 98,830 |
| Cash and cash equivalents at beginning of period | 297,642 | 290,605 | 160,842 | 62,012 |
| Cash and cash equivalents at end of period | 359,056 | 297,642 | 290,605 | 160,842 |
PACS Group, Inc. (PACS)
PACS Group, Inc. (PACS)